The ways for ginsenoside Rh2 to fight against cancer: the molecular evidences <i>in vitro</i> and <i>in vivo</i>.

Authors:
Hu QR; Pan Y; Wu HC; Dai ZZ; Huang QX and 4 more

Journal:
J Ginseng Res

Publication Year: 2022

DOI:
10.1016/j.jgr.2022.09.011

PMCID:
PMC10014223

PMID:
36926617

Journal Information

Full Title: J Ginseng Res

Abbreviation: J Ginseng Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Integrative & Complementary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of competing interest The author declare no conflict of interest."

Evidence found in paper:

"We would like to thank the following funding sources: 10.13039/501100001809The National Natural Science Foundation of China (NO. 81860578), and the Academic and Technical Leaders Training Program of Major Disciplines in Jiangxi Province—Young Talents Programme (NO. 20204BCJ23025)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025